Cargando…

Randomised, open-label, non-inferiority clinical trial on the efficacy and safety of a 7-day vs 14-day course of antibiotic treatment for uncomplicated enterococcal bacteraemia: the INTENSE trial protocol

INTRODUCTION: Enterococcus spp is responsible for 8%–15% of total bacteraemias with an associated global mortality around 23%–30%. Regarding the clinical management of enterococcal bacteraemia, the evidence on the duration of antibiotic treatment is scarce and the studies do not discriminate between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maldonado, Natalia, Rosso-Fernández, Clara M, Portillo-Calderón, Inés, Borreguero Borreguero, Irene, Tristán-Clavijo, Enriqueta, Palacios-Baena, Zaira R, Salamanca, Elena, Fernández-Cuenca, Felipe, De-Cueto, Marina, Stolz-Larrieu, Emilio, Rodriguez-Baño, Jesús, López-Cortés, Luis Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496718/ https://www.ncbi.nlm.nih.gov/pubmed/37673453 http://dx.doi.org/10.1136/bmjopen-2023-075699

Ejemplares similares

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
por: Marín-Candón, Alicia, et al.
Publicado: (2021)

Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: study protocol for a cluster-randomised crossover trial, the NO-BACT study
por: Jiménez-Jorge, Silvia, et al.
Publicado: (2019)

Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial
por: Rogers, Benjamin A, et al.
Publicado: (2023)

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
por: Rosso-Fernández, Clara, et al.
Publicado: (2015)

Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project
por: Palacios-Baena, Zaira R, et al.
Publicado: (2020)

Epidemiology, management and clinical outcomes of ICU-acquired enterococcal bacteraemias
por: Ong, DSY, et al.
Publicado: (2014)

PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
por: Huttner, Angela, et al.
Publicado: (2017)

Short course antibiotic treatment of Gram-negative bacteraemia (GNB5): a study protocol for a randomised controlled trial
por: Tingsgård, Sandra, et al.
Publicado: (2023)

Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021)

Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children
por: Saunderson, Rebecca B, et al.
Publicado: (2014)

Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial
por: Israelsen, Simone Bastrup, et al.
Publicado: (2023)

Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial
por: Burdet, Charles, et al.
Publicado: (2018)

Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment
por: Buis, DTP, et al.
Publicado: (2023)

Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted after long bone fractures (DURATIOM): Protocol for a randomized, pragmatic trial
por: Garrigós, Carmen, et al.
Publicado: (2023)

Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial
por: López-Cortés, Luis Eduardo, et al.
Publicado: (2017)

Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial
por: Kliim-Hansen, Vivian, et al.
Publicado: (2022)

C-reactive protein and the neutrophil-to-lymphocyte ratio on admission predicting bacteraemia with COVID-19
por: Ueda, Yoshitaka, et al.
Publicado: (2023)

Delayed antibiotic exposure induces population collapse in enterococcal communities with drug-resistant subpopulations
por: Hallinen, Kelsey M, et al.
Publicado: (2020)

Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol
por: Anaya-Baz, Blanca, et al.
Publicado: (2020)

Study on the utility of a statewide counselling programme for improving mortality outcomes of patients with Staphylococcus aureus bacteraemia in Thuringia (SUPPORT): a study protocol of a cluster-randomised crossover trial
por: Weis, S, et al.
Publicado: (2017)

Does cranberry extract reduce antibiotic use for symptoms of acute uncomplicated urinary tract infections (CUTI)? A feasibility randomised trial
por: Gbinigie, Oghenekome, et al.
Publicado: (2021)

Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial
por: Smit, Mikaela, et al.
Publicado: (2020)

Infectious diseases in child day care facilities
por: Pickering, Larry K.
Publicado: (1986)

Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia
por: Cheah, Agnes Loo Yee, et al.
Publicado: (2014)

Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia
por: Douglas, Edward JA, et al.
Publicado: (2023)

Impact of a Single-Day Lockdown on COVID-19: An Interrupted Time Series Analysis
por: AlRyalat, Saif Aldeen, et al.
Publicado: (2021)

Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
por: Patel, Vaama, et al.
Publicado: (2022)

Multicentre, randomised, open-label, phase IV–III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: study protocol for the SAFO trial
por: Grillo, Sara, et al.
Publicado: (2021)

Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda
por: Eziefula, Alice Chijioke, et al.
Publicado: (2013)

Effectiveness of antitussives, anticholinergics or honey versus usual care in adults with uncomplicated acute bronchitis: a study protocol of an open randomised clinical trial in primary care
por: Cots, Josep M, et al.
Publicado: (2019)

Bacteraemia predictive factors among general medical inpatients: a retrospective cross-sectional survey in a Japanese university hospital
por: Fukui, Sayato, et al.
Publicado: (2016)

A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection
por: Li, Ying, et al.
Publicado: (2020)

Antibiotics for uncomplicated skin abscesses: systematic review and network meta-analysis
por: Wang, Wen, et al.
Publicado: (2018)

Models for bacteraemia risk prediction. Clinical implications
por: Clemente-Callejo, Carlota, et al.
Publicado: (2022)

Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care—an analysis of the OUTCOMEREA database
por: Morvan, Anne-Cécile, et al.
Publicado: (2019)

Effect of the vancomycin minimum inhibitory concentration on clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis
por: Shi, Changcheng, et al.
Publicado: (2021)

Increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018
por: Piezzi, Vanja, et al.
Publicado: (2020)

The Attributable Factors That Increase the Likelihood of Central Line Associated Blood Stream Infection Related In-Hospital 30-Day Mortality
por: Alotaibi, Naif H, et al.
Publicado: (2023)

The effect of community-acquired bacteraemia on return to workforce, risk of sick leave, permanent disability pension and death: a Danish population-based cohort study
por: Dalager-Pedersen, Michael, et al.
Publicado: (2014)

Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study
por: Albasanz-Puig, Adaia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k7tgddu2t7cl7smnqm9fg0dkud